ABSTRACT: Short-term patterns of growth hormone (GH) secretion and factors affecting it were studied in mares and stallions. In Exp. 1, hourly blood samples were collected from three mares and three stallions in summer and winter. Although GH concentrations varied in a pulsatile manner in all horses, there was no effect of sex or season ( P > .1) on plasma GH concentrations and no indication of a diurnal pattern of GH secretion. In Exp. 2, 10-min blood samples were drawn for 8 h from 12 mares; after 6 h, porcine GH-releasing hormone (GHRHI was administered i.v. at 0,45,90, or 180 pg/mare (three mares per dose). Pulsatile secretion of GH occurred in all mares and averaged 2.4 f .3 peaks/6 h; amplitudes were variable and ranged from 2.6 to 74.4 ng/mL. Eight of nine mares responded within 20 min to GHRH injection, but there was no difference (P > .1) among the three doses tested. In Exp. 3, plasma GH concentrations in stallions increased ( P c .05) 8-to 10-fold after 5 min of acute physical exercise or exposure to an estrual mare. Restraint via a twitch (5 mid and epinephrine administration (3 mg i.v.1 also increased (P c .05) plasma GH concentrations by approximately fourfold. In Exp. 4 and 5, administration of either .4, 2, or 10 mg of thyrotropin-releasing hormone (TRH) or 100 or 500 mg of sulpiride (a dopamine receptor antagonist) increased (P c .01) plasma prolactin concentrations but had no effect (P > .1) on GH concentrations during the same period of time. It is concluded that 1) secretory patterns of GH in the mare and stallion are episodic and(or1 pulsatile in nature, 2) GH secretion is part of the overall hormonal response to stimulation of the sympathetic nervous system, and 3) there is no cosecretion of GH with prolactin in response to TRH or sulpiride.
Introduction
tory species, as well as for monkeys and humans (Christian et al., 1978; Morrison et al., 1981 ; Secretory patterns of growth hormone (GHI Guyton, 1986; Kaler et al., 1986; Dubreuil et al., have been described for various farm and labora-1987; Laurentie et al., 19891 . In general, GH secretion is characterized by pulsatile or episodic periods of high GH concentrations in blood superimposed on either a low, constant baseline 1987) Or On a Christian et d . , 1978;  sheep, Laurentie et al., 1989) . The occurrence of a spontaneous period of high GH secretion is not necessarily correlated with any observable physiological event (Guyton, 19861, baseline although several physical and metabolic factors have been shown to increase GH secretion. These include slow-wave sleep and lying in sheep aaurentie et al., 1989) ; age (youth) in sheep, monkeys, and pigs (Morrison et al., 1981 ; Kaler et al., 1986; Dubreuil et al., 19871;  gender in pigs (Arbona et al., 1988) ; fasting, exercise, trauma, and deep sleep in humans (Guyton, 1986) ; and poor nutritional status in sheep and cattle (Bassett, 1974 ; Driver and Forbes, 1981 ; Granger et al., 1989) .
In addition, GH-releasing hormone (GHRH) from the hypothalamus has been characterized for several species (Bohlen et al., 1983 ; Spiess et al., 1983 ; Ling et al., 19841 , and its injection results in rapid secretion of GH. Although purification of GH from the equine anterior pituitary gland has been described (Conde et al., 1973; Cahill et al., 1987) and its biochemical and immunological properties have been studied (Bewley and Li, 1987;  Fukushima et al., 1987; Mollerach-Gobbi et al., 19901 , there seems to be no information on GH secretion or its regulation in the horse. Thus, the experiments described herein were designed 1) to characterize the short-term pattern of GH secretion in horses and to determine the response to GHRH and 2) to describe the effects of various physiological and pharmacological factors on GH concentrations in plasma.
Materials and Methods
Animals and Blood Samples. Grade, lighthorse mares between 4 and 14 yr of age were kept on pasture and were fed grass hay plus supplemental protein and minerals as needed to maintain good body condition. Mares were checked daily for estrus so that their reproductive status was known. Grade, lighthorse stallions between 6 and 16 yr of age were housed in individual 50-m x 75-m lots and were fed grass hay and a commercial grain ration to maintain good body condition. All stallions were sexually experienced.
In all experiments, blood samples were drawn via jugular catheters and were placed into tubes containing heparin at a final concentration of 20 USP units/mL of blood. Plasma was harvested by centrifugation and was stored at -15OC.
Experiment I . To determine whether GH concentrations in plasma varied in a diurnal manner and whether season influenced the pattern, three mares and three stallions were sampled hourly for 36 h in summer (July) and three different mares and stallions were sampled in winter (January). All animals were placed in stalls in a barn 48 h before the onset of blood sampling. Blood samples (15 mW were drawn beginning at 1000 on d 1. All horses had access to grass hay and water during the Experiment 5. Fifteen mares were used in November to determine the relative effects of a single injection of sulpiride (a dopamine receptor antagonist1 on GH and prolactin concentrations in blood. Five mares each received either 2 mL of vehicle (corn oil) S.C. or 2 mL of oil containing 100 or 500 mg of sulpiride. Blood samples were drawn at -.5, 0, .5, 1, 1.5, 2, 3, 4, 6, and 8 h relative to injection.
Radioimmunoassay of Growth Hormone and Prolactin. Growth hormone was measured by a double-antibody RIA based on antiserum (AFP-10318545) generated against porcine GH (pGH) and highly purified pGH for radioiodination CAFP-10864B1. The pGH was radioiodinated by the chlo-GROWTH HORMONE IN MARES AND STALLIONS 1203 ramine-T method (2.5 pg/pg of GH, 0°C for 30 SI.
The antiserum was diluted 1:150,000 in PBS containing .033 M EDTA, .112% normal rhesus monkey serum (Calbiochem, San Diego, CA), and 33% noninhibitory horse serum; 300 pL of this solution was used per tube. The horse serum was added to minimize and to stabilize nonspecific binding of radioiodinated pGH to the assay tubes. Antiserum (Calbiochem) against rhesus monkey immunoglobulin-G was diluted 1:21 and was used at 200 pL/ tube to precipitate the primary antibody. Crossreactivities of other porcine pituitary hormones (tested between .1 and 500 pg/tube1 in the assay were as follows (percentage relative to pGH): prolactin .08, FSH .12, LH .OOl, and thyroidstimulating hormone .004. Inhibition curves produced by serial dilutions of horse sera, plasmas, and pituitary extracts were parallel to those produced by the reference standard (equine GH; AFP-5622C) as well as by purified pGH (USDApGH-Bl; obtained through the National Hormone and Pituitary Program, Baltimore, MD). Sensitivity of the assay averaged .1 ng; in a typical assay, the sample size was 200 pL. Respective intra-and interassay CV were 8 and 11% for a pool of serum assayed in six separate assays.
Prolactin was measured by double-antibody RIA as described by Colborn et al. (1991) . Sensitivity of the prolactin assay was .04 ng, and the sample size was 100 pL. Intra-and interassay CV were 7 and 1 2 O/ O, respectively .
Statisficd Analyses. Concentrations of GH for mares in Exp. 1 and 2 were subjected to peak analysis via the PULSAR computer program (obtained from V. D. Ramirez, Univ. of Illinois, Urbana) described by Gitzen and Ramirez (1976) . Smoothing time was set at 720 min for data from Exp. 1 and 200 min for data from Exp. 2. Cut-off parameters, G(d, for peaks with one through five points, respectively, were set at 5.78, 2.89, 1.90, 1.50, and 1.20. In addition, a designated peak was only considered significant if the amplitude was at least twice as great as the assay sensitivity. To study the relative informative value of 10-min vs hourly sampling, each data set in Exp. 2 was used to generate a new data set that simulated hourly sampling. This was done by selecting the first and then every sixth data point, for a total of nine points. These data were subjected to PULSAR analysis as described above except that the smoothing time was set at 480 min.
The effects of sex and season on the number of GH peaks in Exp. 1 were assessed by ANOVA with a 2 x 2 factorial arrangement of treatments (Steel and Torrie, 1980) . The effect of GHRH dose on GH peak amplitude in Exp. 2 was assessed by one-way ANOVA.
Data from Exp. 3 were analyzed by split-plot ANOVA with stallions as the random effect (Steel and Torrie, 1980) ; fixed main effects were treatments and sampling times. Before analysis, data from each stallion were placed on a percentage of pretreatment (average of -10 and 0 min samples) basis to eliminate pretreatment variation among stallions; only data from posttreatment samples (10, 20 , and 30 mid were used in the ANOVA. The lsd test was used to determine whether treatment means differed from 100°/~ (Steel and Torrie, 1980) . Data from Exp. 4 and 5 were analyzed by splitplot ANOVA as described by Gill and Hafs (19711. Correlation coefficients for GH and prolactin concentrations were determined for individual animals (Steel and Torrie, 1980) .
Results
Concentrations of GH in hourly samples from mares and stallions during a 36-h period in summer and winter are presented in Figure 1 .
Mean GH concentrations did not vary (P > .1) due to sex or season, although two statlions in summer had baseline GH concentrations that seemed to be exceptionally high compared with those of all other horses. The number of peaks in 36 h was not affected (P > .ll by sex or season and averaged 6.1 f .6. There was considerable variation in the patterns for individual animals.
Concentrations of GH in plasma of mares during the period of 10-min blood sampling are presented in Figure 2 . In the 6 h before injection of GHRH, the 12 mares had an average of 2.4 f .3 peaks in GH concentrations. Amplitude of these peaks ranged from 2.6 to 74.4 ng/mL and averaged 19.9 f 6.3 ng/mL. The duration of most peaks was approximately 60 min. Injection of GHRH increased GH concentrations in eight of nine mares. One mare receiving 180 pg of GHRH did not have a significant rise in GH concentrations within 20 min after injection. For all mares, the mean amplitude of the GH response to GHRH was 44.9 * 16.8, 36.2 f 12.6, and 12.0 f 6.0 ng/mL (P > .1) for mares receiving 45,90, and 180 pg, respectively. In general, the rate of increase in GH concentrations was greater after GHRH administration than it was for the spontaneous peaks.
When the data from Exp. 2 were used to simulate hourly sampling, it was found that 27 (55%) of the 49 peaks detected in Figure 2 ware detected by PULSAR for hourly samples. Of the 27 peaks detected in both analyses, hourly sampling would have properly estimated pulse amplitude in only 8 (30%). In addition, there were four peaks assessed as such by hourly analysis via PULSAR that were not determined as peaks in the 10-min analysis. Regression analysis of the number of peaks for each mare in the two peak analyses yielded a correlation coefficient of .30 (P > .1).
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Relative to pretreatment, concentrations of GH increased (P < .05) 8-to 10-fold in stallions exposed to acute physical exercise and sexual stimulation (Figure 31 . Twitching between prolactin and GH concentrations for these mares ranged from -.61 to .27 (P > .05).
Administration of 100 or 500 mg of sulpiride increased (P < .011 prolactin concentrations in plasma of mares (Figure 5) . Although the mean prolactin concentration at .5 h after injection was greater (P < .05) for mares receiving 500 m g of sulpiride than for mares receiving 100 mg, there was no other difference between the responses of the two groups. Concentrations of GH in these mares were affected neither by sulpiride treatment nor by sampling time (P > .1). Only 1 mare of the 12 (treated with 500 mg of sulpiride) displayed a significant relationship between prolactin and GH concentrations (r = BO; P < .05); the remaining correlation coefficients ranged from -36 to .57.
Discussion
Secretion of GH was pulsatile and(or1 episodic in nature in most of the mares and stallions used in these experiments, which is similar to the pattern reported for several other species. The amplitude of these periods of high GH secretion varied considerably; three mares in Exp. 2 had minimal change in GH concentrations, whereas other mares had up to 30-fold increases. For most pares in Exp. 1 and 2, a stable baseline was &dent, resulting in patterns of GH secretion similar to those reported for pigs and monkeys (Kaler et al., 1986; Dubreuil et al., 1987) . In contrast, stallions in summer tended to have higher and more variable baseline values. Similarly, boars have been found to have greater mean GH concentrations and greater pulse amplitude than gilts CArbona et al., 1988) . More mares and stallions need to be studied to determine whether this apparent difference due to sex in horses persists for a larger sample size.
The response in mares to an i.v. injection of GHRH was also variable among animals, which is similar to results reported for pigs (Kraft et al., 1985; Dubreuil et al., 1987) and rats Wehrenberg et al., 1982) . Of the nine mares administered GHRH, eight exhibited a significant increase in GH concentrations within 20 min after injection, but there was little indication of a dose-response relationship at the doses tested. Determination of such a relationship is difficult given the inherent pulsatile nature of GH secretion. That is, administration of GHRH when GH concentrations are already high due to a spontaneous pulse may not yield the same response as when the injection is given just before the onset of a spontaneous pulse. Moreover, two of the mares in Exp. 2 that received injections of vehicle had significant increases in GH concentrations that occurred within 20 min of the injections. These increases could in fact have been due to the saline-gelatin injection, or they may have been due to spontaneous pulses occurring coincidently with the vehicle injection. Because the shape of these increases in vehicletreated mares resembled the spontaneous pulses more than the responses to GHRH (i.e., they were not as sharply defined), we suspect that they were spontaneous peaks that happened to occur shortly after vehicle injection.
Based on the comparison of lo-min blood sampling in Exp. 2 to simulated hourly sampling, we estimate that only 55% of the peaks actually occurring in Exp. 1 were detected by hourly sampling. There is no reason to suspect that this probability would not be constant throughout the 36-h sampling period, thus the overall peak activ- Pooled SE were 7.7 and 2.6 ng/mL for GH and PRL concentrations, respectively. ity at a given time of day in Figure 1 should be indicative of the actual GH secretory activity at that time. Given this, there was no indication of a diurnal pattern in GH secretion in mares or stallions in either season. Diurnal changes in GH secretion in humans seem to be related to sleepwake cycles (Weitzman, 1976; Guyton, 1986) and perhaps the timing of meals. Because the average amount of pulsatile activity in GH concentrations in mares and stallions tended to be constant throughout the 36-h period, we conclude that blood sampling protocols designed for the convenience of daytime sampling should be adequate for estimating overall GH secretory activity. However, given that a high frequency of sampling is required to estimate peak amplitude, it is possible that a diurnal variation in pulse amplitude could Time (h) Figure 5 . Plasma concentrations of growth hormone (GH) and prolactin (PRL) in mares administered 0, 100, or 500 mg of sulpiride at time 0. Pooled SE were 6.9 and 3.9 ng/mL for GH and PRL concentrations, respectively. have occurred in Exp. 1 without detection by our hourly sampling.
Acute physical exercise and sexual stimulation (which in stallions usually involves considerable physical activity) increased GH secretion in stallions 8-to 10-fold. A similar increase was observed previously for concentrations of cortisol and prolactin in these stallions (Colborn et al., 1991) . Similar increases in GH after exercise have been reported in humans (Guyton, 1986) . Twitching and epinephrine administration also increased GH concentrations, but not to the extent that exercise did. Similarly, twitching resulted in a variable prolactin response and epinephrine administration did not affect prolactin at all (Colborn et al., 1991) . Like cortisol and prolactin, GH seems to be one of several hormones secreted in the horse as part of a generalized stimulation of the sympathetic nervous system (Colborn et al., 19911 .
From the results of Exp. 4 and 5, it was concluded that short-term GH secretion is not affected by two potent secretagogues of prolactin. Thyrotropin-releasing hormone seems to act directly on lactotropes to stimulate prolactin release (Gerschengorn et al., 19791, whereas dopamine receptor antagonists such as sulpiride cause release of prolactin by blocking the inhibitory effects of dopamine (Neill, 1988) . Given the evidence in the rat that a certain percentage of the cells in the anterior pituitary produce both prolactin and GH (Frawley et al., 19851, it would not have been surprising if there were some coincidence in the release of these two hormones after TRH and(or1 sulpiride administration. However, the concentrations of these two hormones were virtually independent of each other in 20 of the 21 mares in Exp. 4 and 5.
In conclusion, secretory patterns of GH in the mare and stallion are episodic and(or1 pulsatile in nature and resemble those observed in pigs and primates. It seems that a rapid increase in GH secretion is part of the overall hormonal response to stimulation of the sympathetic nervous system. Given that neither TRH nor sulpiride administration affected GH secretion, it seems that there is no co-secretion of GH with prolactin under these conditions.
Implications
The experiments described herein have confirmed that horses are similar to other species with regard to the mode of growth hormone secretion (i.e., it is pulsatile or episodic) and some of the factors that affect it. Given this basic information as a starting point, rapid progress should be possible 11 for the further study of growth hormone characteristics in horses of various stages of development and 21 for the manipulation of growth hormone secretion in the horse to the benefit of the horse owner.
